Form4insider filings, from the source

SEC Form 4 · accession 0001225208-26-006578

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Theodora Mistras
Officer — CVP, Chief Financial Officer
Period of report
Jul 9, 2026
Accepted (ET)
Jul 10, 2026 · 5:11 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001099800

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 9, 2026A87,595$0.00A87,595D
Common StockF2Jul 9, 2026A12,325$0.00A99,920D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Acquire)F3$91.33Jul 9, 2026A61,800AJul 9, 2027Jul 8, 2033Common Stock61,80061,800D
Performance RightsF4—Jul 9, 2026A12,325AJul 9, 2029—Common Stock12,32512,325D

Explanation of responses

Remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.